Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer

Front Oncol. 2023 Mar 28:13:1147497. doi: 10.3389/fonc.2023.1147497. eCollection 2023.

Authors

Gianluca Mauri^{1

2

3}, Giorgio Patelli^{1

3}, Viviana Gori^{1

3}, Calogero Lauricella³, Benedetta Mussolin⁴, Alessio Amatu³, Katia Bencardino³, Federica Tosi³, Erica Bonazzina³, Emanuela Bonoldi³, Alberto Bardelli^{4

5}, Salvatore Siena^{1

3}, Andrea Sartore-Bianchi^{1

3}

Affiliations

¹ Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.
² IFOM, Istituto Fondazione di Oncologia Molecolare ETS, Milan, Italy.
³ Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
⁴ Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy.
⁵ Department of Oncology, Università degli Studi di Torino, Turin, Italy.

Abstract

[This corrects the article DOI: 10.3389/fonc.2022.1030232.].

Keywords: MAP2K1; MEK; colorectal cancer; panitumumab; resistance mechanisms.

Copyright © 2023 Mauri, Patelli, Gori, Lauricella, Mussolin, Amatu, Bencardino, Tosi, Bonazzina, Bonoldi, Bardelli, Siena and Sartore-Bianchi.

Publication types

Published Erratum